Branch Retinal Artery Occlusion after Injection of a Long-Acting Risperidone Preparation

  1. Johnny Tang, MD; and
  2. John J. Weiter, MD, PhD
  1. From Retina Specialists of Boston, Harvard Medical School, Schepens Eye Research Institute, and the Massachusetts Eye and Ear Infirmary, Cambridge, MA 02140.

    Background: Adverse events of long-acting risperidone are usually attributed to the drug rather than to its preparation. Microsphere technology used for slow release of risperidone in its long-acting formulation is used for other drugs.

    Objective: To report a case of branch retinal artery occlusion after injection of long-acting risperidone.

    Case Report: A 39-year-old man with a history of psychiatric illness presented to our office with blurred vision in his right eye for 3 days after a right buttock injection of long-acting risperidone (Risperdal Consta, Janssen, Titusville, New Jersey). The patient noted the change in vision about 30 minutes after the injection. He presented to our office 4 …

    « Previous | Next Article »Table of Contents